Envision Healthcare Holdings (EVHC) 23.62 $EVHC AMSURG

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Envision Healthcare Holdings (EVHC) 23.62 $EVHC

AMSURG Announces Second-Quarter Financial Results
BusinessWire - Tue Aug 02, 3:05PM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced financial results for the second quarter and six months ended June 30, 2016. The Company's results for the quarter, compared with the second quarter of 2015, included:
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:36AM CDT
The Medical sector is expected to deliver 5.4% earnings growth on 10.5% higher revenues in the second quarter.
PRXL: 66.11 (-0.36), EVHC: 23.62 (+0.08), CRL: 85.83 (-1.21), HUM: 173.30 (+3.73)

Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 72.18 (+0.14), BSX: 23.82 (-0.35), EVHC: 23.62 (+0.08), GWPH: 95.24 (+1.17), NUVA: 62.69 (+0.06)

Envision Healthcare Holdings, Inc. to Report Operating Results for Second Quarter and First Half of 2016 on August 3, 2016
BusinessWire - Mon Jul 11, 5:00AM CDT
Envision Healthcare Holdings, Inc. (NYSE: EVHC) (Envision) plans to release its operating results for the three months and six months ended June 30, 2016, after the securities markets close on Wednesday, August 3, 2016, with an investor conference call to follow at 5 p.m. Eastern Time.
EVHC: 23.62 (+0.08)

ENVISION HEALTHCARE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AMSURG Corp.
BusinessWire - Fri Jun 24, 1:17PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" (NYSE: EVHC) concerning the sale to AMSURG Corp. (NASDAQ: AMSG). Under the terms of the agreement, Envision shareholders will only receive 0.334 AMSURG shares for each share owned. The consideration is valued at approximately $26.21, which is significantly lower than the 52-week high and at least one analyst's estimated value of $36.00 per share.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

INVESTOR ALERT: Levi & Korsinsky, Notifies Envision Healthcare Holdings, Inc. Shareholders of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
PR Newswire - Thu Jun 23, 12:09PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Envision Healthcare Holdings, Inc. - EVHC
ACCESSWIRE - Wed Jun 22, 8:35PM CDT
BALA CYNWYD, PA / ACCESSWIRE / June 22, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" or "the Company" (NYSE: EVHC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AmSurg Corp. ("AmSurg".
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

SHAREHOLDER ALERT: Levi & Korsinsky, Notifies Shareholders of Envision Healthcare Holdings, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
ACCESSWIRE - Tue Jun 21, 5:16PM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

ENVISION HEALTHCARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Envision Healthcare Holdings, Inc. (EVHC) Over the Proposed Sale of the Company to AmSurg Corp.
PR Newswire - Tue Jun 21, 3:21PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision Healthcare" or the "Company" (NYSE:EVHC) for potential breaches of fiduciary duties in connection with the sale of the Company to AmSurg Corp. ("AmSurg" for approximately $4.73 billion.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Lifshitz & Miller Law Firm Announces Investigation of ChromaDex Corporation, CPI Card Group Inc., Electro Rent Corporation, Elizabeth Arden, Inc., Envision Healthcare Holdings, Inc., FEI Company, Polonia Bancorp, Inc., and SciQuest, Inc.
PR Newswire - Tue Jun 21, 12:19PM CDT
ChromaDex Corporation (CDXC)
EVHC: 23.62 (+0.08), RDEN: 13.91 (+0.01), PMTS: 4.60 (unch), SQI: 17.75 (unch), CDXC: 4.00 (+0.17), ELRC: 15.48 (+0.01), FEIC: 106.79 (+0.14)

Envision Healthcare Holdings Inc. Acquisition May Not Be in the Best Interests of EVHC Shareholders
PR Newswire - Mon Jun 20, 10:30AM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company" in connection with the Company's proposed plan of merger with AmSurg Corp. ("AmSurg", announced on June 15, 2016. Under the terms of the agreement, EVHC shareholders will receive 0.334 of a share of AmSurg common stock for each EVHC share they own, representing consideration of $25.89 per share.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Ryan & Maniskas, LLP Announces Investigation of Envision Healthcare Holdings, Inc.
PR Newswire - Fri Jun 17, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Envision Healthcare Holdings, Inc. ("Envision" or the "Company" (NYSE: EVHC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to AmSurg Corp. ("AmSurg" in a transaction valued at approximately $4.8 billion.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08), BAX: 48.06 (-0.42), LMAT: 17.63 (+0.24)

Robbins Arroyo LLP: Acquisition of Envision Healthcare Holdings, Inc. (EVHC) by AmSurg Corp. (AMSG) May Not Be in Shareholders' Best Interests
BusinessWire - Thu Jun 16, 1:14PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Envision Healthcare Holdings, Inc. (NYSE: EVHC) by AmSurg Corp. (NASDAQ: AMSG). On June 15, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which AmSurg will acquire Envision. Under the terms of the agreement, Envision shareholders will receive 0.334 shares of AmSurg common stock for each share of Envision common stock, the value of which is equivalent to $26.21.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Envision Healthcare and AMSURG Announce Transformational Merger
BusinessWire - Wed Jun 15, 3:30PM CDT
Envision Healthcare Holdings, Inc. (Envision) (NYSE:EVHC) and AMSURG Corp. (AMSURG) (NASDAQ:AMSG) today announced that they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction at a fixed exchange ratio of 0.334 AMSURG shares per Envision share. The combined organization will have a pro forma market capitalization of approximately $10 billion and enterprise value of approximately $15 billion based on the closing stock prices of Envision and AMSURG on June 14, 2016. Envision shareholders will own approximately 53% percent and AMSURG shareholders will own approximately 47% percent of the combined organization on a fully diluted basis, including preferred shares. The transaction has been unanimously approved by the Boards of Directors of both companies.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Envision Healthcare (EVHC) in Focus: Stock Climbs 8.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:35AM CDT
Envision Healthcare Holdings, Inc. (EVHC) was a big mover last session, as the company saw its shares rise over 8% on the day.
AMSG: 72.18 (+0.14), EVHC: 23.62 (+0.08)

Ventas Board Appoints James D. Shelton as Presiding Director
BusinessWire - Tue May 10, 6:56PM CDT
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company" said today its Board of Directors (the "Board" has appointed James D. ("Denny" Shelton to serve as the Company's independent presiding director. Douglas Crocker II, who served the Company as independent presiding director for 13 years, has retired from the Board in connection with the Company's retirement policy.
OCR: 97.90 (-0.02), EVHC: 23.62 (+0.08), VTR: 73.73 (-0.72)

Envision Healthcare Holdings, Inc. To Participate at Bank of America Merrill Lynch 2016 Healthcare Conference May 10, 2016
BusinessWire - Fri May 06, 7:00AM CDT
Envision Healthcare Holdings, Inc. (Envision) (NYSE: EVHC) intends to participate at the upcoming Bank of America Merrill Lynch 2016 Healthcare Conference in Las Vegas, NV. Randy Owen, Envision's chief operating officer and chief financial officer, is scheduled to participate in a "fireside chat" discussion on Tuesday, May 10, 2016, at 1 p.m. Pacific Time
EVHC: 23.62 (+0.08)

Envision Healthcare beats Street 1Q forecasts
Automated Insights - Thu May 05, 4:31PM CDT
GREENWOOD VILLAGE, Colo. (AP) _ Envision Healthcare Holdings Inc. (EVHC) on Thursday reported first-quarter earnings of $26.9 million.
EVHC: 23.62 (+0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 23

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 11

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 13

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 28

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 21

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 21

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 20

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 33

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Groundbreaking for New Community by Century Communities

Updated Category News Views 191

Century Communities Breaks Ground on New Development Century Communities, Inc. (NYSE: CCS) has recently made headlines with the groundbreaking of its newest venture: a magnificent 318-acre community named Mirabella. This family-friendly location promises to provide over 1,000 new homes designed for affordability and comfort. Situated within the bustling west metro area of...

Continue Reading
Perseus Group Enhances Manufacturing Software with OptiVision

Updated Category News Views 105

Perseus Group Strengthens Its Position in the Industry Perseus Group, a dynamic operating group within Constellation Software Inc., has taken a significant step in enhancing its offerings in the pulp and paper sector. They recently announced the completion of an exciting acquisition that will support their growth strategy. The group has secured the exclusive global...

Continue Reading
Embrace Pet Insurance Breaks Records in Volunteerism and Giving

Updated Category News Views 267

Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...

Continue Reading
Biocon Biologics Achieves Key FDA Approval for Jobevne™ in Oncology

Updated Category News Views 173

Biocon Biologics Secures FDA Approval for Jobevne™ Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for Jobevne™ (bevacizumab-nwgd). This biosimilar to the well-known Avastin (bevacizumab) is designed for intravenous use and aims to treat various types of cancer....

Continue Reading